Clarapath has released an updated FDA-registered SectionStar robotic microtomy system, developed with histotechnologists to enhance efficiency and consistency in clinical histology labs amid staffing and case volume challenges.
The system offers faster run times and reduced sample consumption for the analysis of viral vectors, protein aggregates, and advanced materials.
A University of Warwick study finds AI cancer detection models may rely on statistical correlations rather than true biomarker signals, raising concerns about reliability in clinical pathology applications.
ViewsML will present an AI platform at USCAP 2026 that predicts biomarker expression from standard H&E slides, enabling per-cell spatial analysis without additional staining, according to the company.
The multi-year collaboration includes the deployment of the AISight Dx platform and AI algorithms across the health system’s laboratory network.
The FDA has cleared Roche’s cobas c 703 and cobas ISE neo, high-throughput analytical units designed to automate workflows and address staffing and capacity challenges.
Increased adoption of flow cytometry and artificial intelligence tools helps clinicians manage the rising number of indeterminate pulmonary nodules.
The test allows for simultaneous detection of multiple viruses on a sample-to-answer platform designed for immunocompromised patients.
The diagnostic tool identifies a specific biological cause of autism with more than 97% predictive accuracy.
n6 has launched the icon16, a 16-well NGS library prep instrument for low-throughput clinical and research labs, featuring per-well real-time amplification control using the company’s AutoNorm technology.
A proof-of-concept study shows that bacteria-metabolized molecules enriched with carbon-13 produce detectable exhaled CO2, enabling rapid infection identification with inexpensive infrared scanners.
Biodesix will present seven abstracts—including two oral sessions—at AACR 2026, highlighting advances in automated myeloid testing, liquid biopsy, and NGS-based cancer monitoring platforms.
The cobas liat system delivers PCR results in 15 minutes, detecting and differentiating between three Bordetella pathogens including whooping cough.
A rapid urine test identified effective UTI antibiotics in an average of 5.85 hours, matching standard lab accuracy in a University of Reading study published in the Journal of Antimicrobial Chemotherapy.